20,693 Shares in Encompass Health Corporation (NYSE:EHC) Purchased by Guided Capital Wealth Management LLC

Guided Capital Wealth Management LLC purchased a new stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 20,693 shares of the company's stock, valued at approximately $2,096,000. Encompass Health makes up 1.8% of Guided Capital Wealth Management LLC's investment portfolio, making the stock its 17th biggest position.

A number of other hedge funds and other institutional investors have also bought and sold shares of EHC. State of Alaska Department of Revenue boosted its holdings in Encompass Health by 2.5% during the 1st quarter. State of Alaska Department of Revenue now owns 13,006 shares of the company's stock worth $1,316,000 after acquiring an additional 315 shares during the last quarter. QRG Capital Management Inc. boosted its holdings in Encompass Health by 2.2% during the 1st quarter. QRG Capital Management Inc. now owns 15,930 shares of the company's stock worth $1,613,000 after acquiring an additional 341 shares during the last quarter. Fifth Third Bancorp boosted its holdings in Encompass Health by 88.7% during the 1st quarter. Fifth Third Bancorp now owns 4,290 shares of the company's stock worth $434,000 after acquiring an additional 2,017 shares during the last quarter. SG Americas Securities LLC boosted its holdings in Encompass Health by 737.0% during the 1st quarter. SG Americas Securities LLC now owns 25,084 shares of the company's stock worth $2,541,000 after acquiring an additional 22,087 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in Encompass Health by 21.5% during the 1st quarter. GAMMA Investing LLC now owns 2,366 shares of the company's stock worth $240,000 after acquiring an additional 419 shares during the last quarter. Institutional investors own 97.25% of the company's stock.

Encompass Health Stock Performance

NYSE EHC traded down $0.68 during trading on Friday, hitting $119.07. 1,297,450 shares of the company's stock traded hands, compared to its average volume of 703,348. The stock has a market capitalization of $12.00 billion, a price-to-earnings ratio of 24.60, a PEG ratio of 2.42 and a beta of 0.89. Encompass Health Corporation has a 12-month low of $82.74 and a 12-month high of $123.13. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.06 and a current ratio of 1.06. The business has a 50 day moving average of $115.81 and a 200-day moving average of $103.99.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.19 by $0.18. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The company's revenue for the quarter was up 10.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.12 earnings per share. As a group, equities research analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.57%. The ex-dividend date is Tuesday, July 1st. Encompass Health's dividend payout ratio (DPR) is currently 14.05%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on EHC shares. Stephens raised shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a report on Thursday, June 5th. Wall Street Zen downgraded shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. Royal Bank Of Canada boosted their price target on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a report on Monday, April 28th. Truist Financial reissued a "buy" rating and issued a $135.00 price target (up from $116.00) on shares of Encompass Health in a report on Monday, April 28th. Finally, UBS Group boosted their price target on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a report on Monday, April 28th. Eight investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $127.00.

Insider Activity at Encompass Health

In other Encompass Health news, EVP John Patrick Darby sold 10,000 shares of the firm's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the transaction, the executive vice president now owns 79,710 shares of the company's stock, valued at approximately $9,149,910.90. This trade represents a 11.15% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Mark J. Tarr sold 118,384 shares of the firm's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the transaction, the chief executive officer now directly owns 527,070 shares of the company's stock, valued at $64,054,817.10. This represents a 18.34% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 132,663 shares of company stock worth $16,034,082 over the last quarter. Corporate insiders own 2.00% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.